Tuscaloosa Research & Education Advancement Corporation
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Tuscaloosa Research & Education Advancement Corporation sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).
Tuscaloosa Research & Education Advancement Corporation: 11 sponsored US clinical trials, none currently recruiting.
Tuscaloosa Research & Education Advancement Corporation sponsors 11 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 9 completed. 7 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is PTSD, with 1 trials.
Top-decile sponsor footprint
Tuscaloosa Research & Education Advancement Corporation ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
9 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
11 total, page 1 of 1
Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans
NCT00659230
Alabama Veterans Rural Health Initiative
NCT01394081
Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
NCT00315900
Carbamazepine Extended-Release for the Treatment of Bipolar Depression
NCT00203567
Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years
NCT00230893
A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction
NCT00203476
Characterization of Recently Deployed Veterans
NCT00451659
Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder
NCT00203528
Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial
NCT00203450
Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder
NCT00203385
Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)
NCT00203463
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 6 |
Therapeutic Areas
How the Tuscaloosa Research & Education Advancement Corporation archive is shaped
11 indexed studies, none listed as recruiting (0% open); 9 completed (82%).
Phase mix: 7 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: PTSD (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Tuscaloosa Research & Education Advancement Corporation: archived-pipeline peers nationwide
Peers matched on 11 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Tuscaloosa Research & Education Advancement Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 11 archived trials
- Aderans Research Institute · 11 trials · 0% recruiting
- Aegerion Pharmaceuticals · 11 trials · 0% recruiting
- Allena Pharmaceuticals · 11 trials · 0% recruiting
- AOBiome · 11 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Tuscaloosa Research & Education Advancement Corporation page
11 registered trials is a research-attention snapshot, not an endorsement of Tuscaloosa Research & Education Advancement Corporation or any single study.
- None of Tuscaloosa Research & Education Advancement Corporation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- PTSD is the condition Tuscaloosa Research & Education Advancement Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See PTSD trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Tuscaloosa Research & Education Advancement Corporation pipeline card: 11 registered trials from official public datasets.Report a data error.